Fortress Biotech News

Fortress Biotech Analyst Ratings

BenzingaMay 16 13:41 ET

Analysts Are Bullish on Top Healthcare Stocks: Fortress Biotech (FBIO), BioLife Solutions (BLFS)

TipRanksMay 16 12:10 ET

Analysts Conflicted on These Healthcare Names: Fortress Biotech (FBIO), GoodRx Holdings (GDRX) and Adaptimmune Therapeutics (ADAP)

TipRanksMay 16 05:10 ET

Buy Rating Affirmed: A Promising Outlook for Fortress Biotech Amid Upcoming Regulatory Milestones and Strategic Investments

TipRanksApr 9 06:17 ET

Alliance Global Partners Initiates Fortress Biotech at Buy Rating With $5 Price Target

MT NewswiresMar 19 10:15 ET

Fortress Biotech Analyst Ratings

BenzingaMar 19 08:19 ET

Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5

BenzingaMar 19 08:20 ET

Fortress Biotech Analyst Ratings

BenzingaMar 15 08:50 ET

Analysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO) and Phreesia (PHR)

TipRanksMar 15 04:50 ET

Roth MKM Maintains Buy on Fortress Biotech, Lowers Price Target to $15

BenzingaNov 29, 2023 09:01 ET

Fortress Biotech Analyst Ratings

BenzingaNov 29, 2023 08:59 ET

B. Riley Trims Fortress Biotech's Price Target to $4 From $6, Keeps Buy Rating

MT NewswiresAug 22, 2023 08:02 ET

Cantor Fitzgerald Reiterates Overweight on Fortress Biotech, Maintains $5 Price Target

BenzingaAug 15, 2023 10:28 ET

Fortress Biotech Analyst Ratings

BenzingaAug 15, 2023 10:27 ET

Cantor Fitzgerald Maintains Overweight on Fortress Biotech, Lowers Price Target to $5

BenzingaMay 16, 2023 07:25 ET

Benchmark Reiterates Speculative Buy on Fortress Biotech, Maintains $5 Price Target

BenzingaApr 6, 2023 08:02 ET

Dawson James Remains a Buy on Fortress Biotech (FBIO)

TipRanksAug 14, 2022 08:30 ET

Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF), Spectrum Pharmaceuticals (SPPI) and Fortress Biotech (FBIO)

TipRanksAug 12, 2022 06:30 ET

Fortress Biotech Initiated at Buy by Ladenburg Thalmann

Dow JonesAug 4, 2022 07:34 ET

Fortress Biotech Price Target Announced at $6.00/Share by Ladenburg Thalmann

Dow JonesAug 4, 2022 07:32 ET